CAT
Caterpillar Inc.
CAT's fundamentals are strong, but it looks expensive: trading at 24x earnings, above its usual 18x. Analysts expect strong earnings growth, though they disagree widely on how much.
CLIR
ClearSign Technologies Corporation
There isn't enough reported data to score CLIR yet.
CAT Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Strong | |
| Strong |
CAT's revenue, profitability, cash flow and balance sheet are all currently healthy.
CLIR Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Under pressure | |
| Weak | |
| Unavailable |
CLIR's revenue is currently healthy, but its profitability and cash flow are under pressure. There isn't enough data to rate its balance sheet.
CAT PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 15x | $380 | -37% |
| Fair | 18x | $461 | -24% |
| Forward | 20x | $605 | — |
| Current | 24x | $605 | — |
| Expensive | 33x | $840 | +39% |
Historical ranges are pointers, not guarantees.
CAT's PE is in its expensive range at 24x. If earnings grow as analysts expect, today's price would be 20x next year's earnings, in its fair range.
CLIR PE Valuation
CLIR has no meaningful PE right now: it lost money over the past year.
CAT Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Moderate | |
| Low |
Analysts expect earnings and revenue growth for CAT, with profitability improving. However, they disagree widely on these estimates.
CLIR Forward outlook
There aren't enough analyst estimates for CLIR to show an outlook.
CAT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $30.32 | +19% |
| Q3 2026 | $25.48 | +31% |
| Q2 2026 | $23.23 | +18% |
| Q1 2026 | $20.08 | -2% |
| Q4 2025 | $18.81 | -15% |
| Q3 2025 | $19.46 | -9.7% |
| Q2 2025 | $19.64 | -10% |
| Q1 2025 | $20.50 | -7.4% |
| Q4 2024 | $22.05 | +9.6% |
CAT has the edge over CLIR on earnings quality, reporting a profit while its opponent remains loss making.
CLIR Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$0.97 | +$0.13 |
| Q1 2026 | -$1.05 | +$0.15 |
| Q4 2025 | -$1.06 | +$0.04 |
| Q3 2025 | -$1.20 | $0.00 |
| Q2 2025 | -$1.10 | +$0.20 |
| Q1 2025 | -$1.20 | +$0.10 |
| Q4 2024 | -$1.10 | +$0.30 |
| Q3 2024 | -$1.20 | +$0.20 |
CLIR is still losing money, but far less than before: $0.97 per share over the past year, against $2.30 at its worst in early 2022.
CAT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $20.7B | +17% |
| Q2 2026 | $20.5B | +24% |
| Q1 2026 | $17.4B | +22% |
| Q4 2025 | $19.1B | +18% |
| Q3 2025 | $17.6B | +9.5% |
| Q2 2025 | $16.6B | -0.7% |
| Q1 2025 | $14.2B | -9.8% |
| Q4 2024 | $16.2B | -5% |
CAT's revenue has grown year over year for five quarters in a row: $20.7B last quarter, up 17% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | +3.1 points |
| Q2 2026 | 21% | +3.6 points |
| Q1 2026 | 18% | -0.4 points |
| Q4 2025 | 14% | -4.1 points |
| Q3 2025 | 17% | -2.2 points |
| Q2 2025 | 17% | -3.6 points |
| Q1 2025 | 18% | -4.2 points |
| Q4 2024 | 18% | -0.3 points |
CAT has the edge over CLIR on profitability, with a higher operating margin.
CLIR Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $560K | +321% |
| Q1 2026 | $191K | -52% |
| Q4 2025 | $3.7M | +522% |
| Q3 2025 | $1M | -45% |
| Q2 2025 | $133K | +196% |
| Q1 2025 | $401K | -64% |
| Q4 2024 | $590K | -54% |
| Q3 2024 | $1.9M | +2087% |
CLIR's revenue is growing: $560,000 last quarter, up 321% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -268% | +1115 points |
| Q1 2026 | -1193% | -630 points |
| Q4 2025 | -23% | +260 points |
| Q3 2025 | -170% | -93 points |
| Q2 2025 | -1382% | +3367 points |
| Q1 2025 | -563% | -449 points |
| Q4 2024 | -282% | -192 points |
| Q3 2024 | -77% | +1684 points |
CLIR's operating margin was −268% last quarter, up 1114 points from the same quarter a year ago.
CAT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $3.7B | +19% |
| Q2 2026 | $3.8B | +47% |
| Q1 2026 | $1.1B | +97% |
| Q4 2025 | $2.7B | +0.1% |
| Q3 2025 | $3.1B | -1.5% |
| Q2 2025 | $2.6B | -4.2% |
| Q1 2025 | $579M | -63% |
| Q4 2024 | $2.7B | -22% |
CAT has the stronger cash trend. Its trailing FCF is up 39% versus its history, compared with CLIR at up 13%.
CLIR Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q4 2025 | -$1.3M | -$847K |
| Q3 2025 | -$1.8M | -$398K |
| Q1 2025 | -$1.1M | -$114K |
| Q4 2024 | -$436K | +$1M |
| Q4 2023 | -$1.5M | -$717K |
| Q4 2022 | -$733K | +$439K |
| Q3 2022 | -$917K | +$992K |
| Q2 2022 | -$1.8M | +$288K |
CLIR has burned cash in almost every quarter: −$5M over the past year, against −$4M the year before.
CAT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.3% | -1.6M shares |
| 1 year | -2.1% | -9.9M shares |
| 3 years | -10% | -51.7M shares |
| 5 years | -16% | -86.7M shares |
| Available history | -19% | -107M shares |
CAT has the edge over CLIR on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1.2B |
| Q2 2026 | $1.5B |
| Q1 2026 | $5B |
| Q4 2025 | $340M |
| Q3 2025 | $362M |
| Q2 2025 | $828M |
| Q1 2025 | $3.7B |
| Q4 2024 | $640M |
CAT spent $8.1B buying back its own shares over the past year, up 47% from the year before.
CLIR Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +5.4% | +304K shares |
| 1 year | +7.4% | +410K shares |
| 3 years | +54% | +2.1M shares |
| 5 years | +89% | +2.8M shares |
CLIR has 6M diluted shares, up 7.4% from a year ago.
CAT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.5x | Net Cash |
| Q2 2026 | -0.4x | Net Cash |
| Q1 2026 | -0.3x | Net Cash |
| Q4 2025 | 2.0x | Healthy |
| Q3 2025 | -0.6x | Net Cash |
| Q2 2025 | -0.4x | Net Cash |
| Q1 2025 | -0.3x | Net Cash |
| Q4 2024 | 1.6x | Healthy |
CAT has more cash than debt.
CLIR Net Leverage
CLIR's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
CAT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.7 | Neutral |
| Stochastic | 6.7 | Oversold |
CAT's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
CLIR Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 30.8 | Neutral |
| Stochastic | 6.6 | Oversold |
CLIR's weekly RSI is 31 (neutral) and its Stochastic is 7 (oversold).
CAT PE vs Industrials Sector
| Metric | CAT | Sector median | Relative |
|---|---|---|---|
| PE | 24x | 24x | 1.3% below |
| PE % | 69 | 58 | 11 pts above |
CAT is trading at 24x earnings, in line with the Industrials sector's median of 24x.
CLIR PE vs Industrials Sector
CLIR has no meaningful PE right now: it lost money over the past year.
CAT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $709.0 | 15% below |
| 20 week MA | $797.0 | 24% below |
| 50 week MA | $771.3 | 22% below |
| 100 week MA | $586.7 | 3.2% above |
| 200 week MA | $443.1 | 37% above |
CAT has the edge over CLIR on trend strength, trading above more of its moving averages.
CLIR Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $2.73 | 17% below |
| 20 week MA | $3.48 | 35% below |
| 50 week MA | $4.60 | 51% below |
| 100 week MA | $6.21 | 64% below |
| 200 week MA | $8.03 | 72% below |
CLIR is in a downtrend: it's below all five of its weekly moving averages, and 72% below its 200-week average.
CAT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $148.3 | $179.6 | +21% |
| 2021 | $179.6 | $206.2 | +15% |
| 2022 | $206.2 | $239.9 | +16% |
| 2023 | $239.9 | $295.7 | +23% |
| 2024 | $295.7 | $364.9 | +23% |
| 2025 | $364.9 | $583.0 | +60% |
| 2026 YTD | $583.0 | $605.3 | +3.8% |
CAT has the edge over CLIR on returns for 2026, with the stronger performance.
CLIR Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $7.70 | $33.5 | +335% |
| 2021 | $33.5 | $14.5 | -57% |
| 2022 | $14.5 | $6.40 | -56% |
| 2023 | $6.40 | $11.1 | +73% |
| 2024 | $11.1 | $12.2 | +9.9% |
| 2025 | $12.2 | $6.09 | -50% |
| 2026 YTD | $6.09 | $2.26 | -63% |
CLIR's yearly returns have swung widely, from +335% in 2020 to −57% in 2021. It's down 63% so far in 2026.